Orapred Website Taken Down After FDA Warning; Corrected Site Will Return
This article was originally published in The Pink Sheet Daily
Executive Summary
BioMarin’s website for the oral corticosteroid underplayed risk, broadened its indication and made unsubstantiated claims, DDMAC says.
You may also be interested in...
Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links
Firms will need to redesign sponsored links that appear on Internet search engines or forgo using them at all, food and drug attorneys suggest following the agency's recent cluster of letters citing the promotions
Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links
Firms will need to redesign sponsored links that appear on Internet search engines or forgo using them at all, food and drug attorneys suggest following the agency's recent cluster of letters citing the promotions
Alcon Gets Third FDA Warning On Sales Claims For Eye And Ear Drugs
Nevanac joins Cipro HC Otic and Travaton in being cited by the agency’s advertising division.